In Africa, pregnant women and young children are the most vulnerable to malaria.

However, malaria control interventions and strategies have achivied important results in the last years.

COVID-19 has now made these interventions critical, and could undo the results obtained so far, as highlighted by scientists in the Lancet: https://bit.ly/2Tfyxwn.

Potentially, COVID-19 could indirectly cause more deaths than it already does directly, in the context of Africa’s weak and fragile health systems.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

INTEGRATION

“This project will improve malaria prevention strategies for both children, pregnant women and families as a whole as the study is being conducted in families which will raise awareness of

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO),

Ebola outbreak in Republic Democratic of the Congo: switching from MEURI (Monitored Emergency Use of Unregistered and Investigational Interventions) to a RCT (Randomized Clinical Trial) for 4 experimental medications in the treatment of Ebola Virus Disease

An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The randomized, controlled trial is